Almac expands development offering with Xcelodose

Related tags Almac pharma services Pharmacology

Almac Pharma Services has bolstered its product development offering with a new Xcelodose 600s precision powder micro-dosing system that, it claims, can cut processing time, API usage and costs.

The UK contract manufacturing organisation (CMO) said that the technology will be installed and operational at its facility in Carigavon, UK by the end of next month.

The new system has the ability to dispense small quantities of fill formulations or active pharmaceutical ingredients (API) directly into capsules with a high level of accuracy.

Company technical development manager John McQuaid explained that the investment was motivated by changing demand and the adoption of new time saving strategies by early-phase manufacturing customers

Whilst Almac has always offered API in capsule shells, we now see examples of some clients maintaining this approach through to phase 2 studies in an attempt to compress their overall development timelines, requiring significant quantities of capsules for which an automated solution is best​."

Related news

Show more

Related products

show more

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 09-Jun-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Related suppliers

Follow us


View more